Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $56,907,995 | $102,647,689 | $98,324,658 | $74,678,086 |
| - Cash | $6,409,000 | $6,804,000 | $12,337,000 | $11,598,000 |
| + Debt | $36,120,000 | $35,471,000 | $36,456,000 | $36,116,000 |
| Enterprise Value | $86,618,995 | $131,314,689 | $122,443,658 | $99,196,086 |
| Revenue | $21,403,000 | $21,960,000 | $23,565,000 | $20,975,353 |
| % Growth | -2.5% | -6.8% | 12.3% | – |
| Gross Profit | $8,675,000 | $10,454,000 | $10,104,000 | $9,239,038 |
| % Margin | 40.5% | 47.6% | 42.9% | 44% |
| EBITDA | -$2,258,000 | $4,935,000 | $5,857,000 | $5,216,802 |
| % Margin | -10.5% | 22.5% | 24.9% | 24.9% |
| Net Income | -$3,471,000 | $2,388,000 | $1,045,000 | $2,295,869 |
| % Margin | -16.2% | 10.9% | 4.4% | 10.9% |
| EPS Diluted | -7.82 | 5.38 | 2.35 | 5.09 |
| % Growth | -245.4% | 128.9% | -53.8% | – |
| Operating Cash Flow | $3,354,000 | $1,805,000 | $3,720,184 | $2,438,741 |
| Capital Expenditures | -$1,379,000 | -$1,197,000 | -$1,625,000 | -$2,834,614 |
| Free Cash Flow | $1,975,000 | $608,000 | $2,115,379 | -$395,874 |